ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Launched by UNIVERSITY OF MINNESOTA · Nov 16, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is called "Assessing the Gay Male Experience with Anal Cancer Prevention Strategies." It aims to understand how men who have sex with men (MSM) feel about anal cancer screening and what they know about it. By using a large survey shared on social media, the study wants to learn about their experiences and opinions on care that helps reduce the risk of anal cancer.
To participate in this study, you need to be at least 18 years old, live in the U.S., and have sexual relationships with male partners. You should also be comfortable speaking either English or Spanish. If you join the study, you'll be asked to fill out a survey about your knowledge and experiences related to anal cancer screening. This research is important because it can help improve awareness and healthcare strategies for anal cancer prevention among MSM.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age
- • Current resident of the U.S.
- • Engage in anoreceptive intercourse with male partners
- • Fluent in English or Spanish
- Exclusion Criteria:
- • Under the age of 18 years old
- • Not living in the United States
- • Not born with sex assigned at birth as male
- • Does not engage in sex with male partners
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Elliot Arsoniadis, M.D., Ph.D
Principal Investigator
University of Minnesota
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials